Research progress of non-coding RNA in atrial fibrillation

Atrial fibrillation (AF) is a common arrhythmia in clinic, and its incidence increasing year by year. In today's increasingly prevalent society, ageing poses huge challenge to global healthcare systems. AF not only affects patients' quality of life, but also causes thrombosis, heart failure other complications severe cases. Although there are some measures for the diagnosis treatment AF, specific serum markers targeted therapy still lacking. recent years, ncRNAs have become hot topic cardiovascular disease research. These involved occurrence development pathophysiological processes such as myocardial infarction atherosclerosis, potential biomarkers diseases. We believe that understanding mechanism study targets can form more systematic framework provide convenience individuals with society.